• Clinical science

Multiple endocrine neoplasia

Summary

Multiple endocrine neoplasia (MEN) is a term used to describe three autosomal dominant syndromes that are associated with certain hormone-producing neoplasias. There are three subtypes: MEN 1, MEN 2A, and MEN 2B. MEN 1 is caused by an altered menin protein expression and presents with primary hyperparathyroidism, often in association with endocrine pancreatic tumors and/or pituitary adenomas. MEN 2A and MEN 2B are caused by a mutated RET proto-oncogene and both present with medullary thyroid carcinoma and sometimes pheochromocytoma. MEN 2A is further associated with primary hyperparathyroidism as well, while MEN 2B causes a marfanoid habitus and sometimes neurinomas. If any of the individual conditions associated with MEN are suspected, especially in patients with a positive family history, it is important to consider a diagnostic workup for any of the other associations. Specific diagnostic and management approaches can be found within the articles for each of the individual conditions. Family members of MEN patients should receive genetic counseling. Those positive for mutated genes should be closely monitored and should undergo a total thyroidectomy if positive for the RET proto-oncogene.

Overview

Feature MEN 1 (formery known as Wermer syndrome) MEN 2
MEN 2A (formerly known as Sipple syndrome) MEN 2B
Genetics
Inheritance
Prinicipal manifestations
Further manifestations

Management

MEN 1: 3 "P"s = Parathyroid, Pancreas, Pituitary gland

MEN 2A: 1 "M", 2 "P”s = Medullary thyroid carcinoma, Pheochromocytoma, Parathyroid

MEN 2B: 2 “M”s, 1 “P” = Medullary thyroid carcinoma, Marfanoid habitus/Multiple neuromas, Pheochromocytoma

Remembering that the inheritence pattern of MEN syndromes is autosomal dominant requires MENtal dominance.

References:[1][2][3][4]

last updated 10/11/2020
{{uncollapseSections(['jI0_ch', 'RJXlF_'])}}